Skip to main content

Protein-Polysaccharide Conjugation

  • Protocol

Part of the Methods in Molecular Medicine™ book series (MIMM,volume 66)


The use of bacterial capsular polysaccharides as immunoprophylactic agents in human diseases caused by encapsulated bacteria is now firmly established (1). However, despite their many advantages, they do have serious limitations. First, they induce an inadequate immune response in infants (2), the section of the population most vulnerable to bacterial meningitis, and second, some polysaccharides are only weakly immunogenic in adults. To overcome these deficiencies, a new generation of semisynthetic vaccines have been developed based on the conjugation of polysaccharide to protein carriers.


  • Bacterial Meningitis
  • Tetanus Toxoid
  • Reductive Amination
  • Sodium Periodate
  • Sodium Cyanoborohydride

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

USD   49.95
Price excludes VAT (USA)
  • DOI: 10.1385/1-59259-148-5:49
  • Chapter length: 6 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
USD   109.00
Price excludes VAT (USA)
  • ISBN: 978-1-59259-148-0
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   149.99
Price excludes VAT (USA)
Hardcover Book
USD   229.00
Price excludes VAT (USA)
Fig. 1.
Fig. 2.

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more


  1. Jennings, H. J. (1990) Capsular polysaccharides as vaccine candidates. Curr. Top. Microbiol. Immunol. 150, 97–127.

    CAS  PubMed  Google Scholar 

  2. Gotschlich, E. C., Lepow, M. L., and Gold, R. (1977) The immune response to bacterial polysaccharides in man, in Antibodies in Human Diagnostics and Therapy (Haber, E. and Krause, R. M., eds.), Raven Press, New York, pp. 391–402.

    Google Scholar 

  3. Jennings, H. J. and Sood, R. K. (1994) Synthetic glycoconjugates as human vaccines, in Neoglycoconjugates: Preparation and Applications (Lee, Y. C. and Lee, R. T., eds.), Academic Press, San Diego, pp. 325–371.

    Google Scholar 

  4. Jennings, H. J. and Lugowski, C. (1981) Immunochemistry of group A, B and C meningococcal polysaccharide-tetanus toxoid conjugates. J. Immunol. 127, 1011–1018.

    CAS  PubMed  Google Scholar 

  5. Schwartz, B. A. and Gray, G. R. (1977) Proteins containing reductively animated disaccharides. Synthesis and chemical characterization. Arch. Biochem. Biophy. 181, 542–549.

    CAS  CrossRef  Google Scholar 

  6. Beuvery, E. C., Roy, R., Kanhai, V., and Jennings, H. J. (1986) Characteristics of two types of meningococcal group C polysaccharide conjugates using tetanus toxoid as carrier protein. Dev. Biol. Stand. 65, 197–204.

    CAS  PubMed  Google Scholar 

  7. Bhattacharjee, A. K., Jennings, H. J., Kenny, C. P., Martin, A., and Smith, I. C. P. (1975) Structural determination of the sialic acid polysaccharide antigens of Neisseria mentingitis serogroups B and C with carbon 13 nuclear magnetic resonance. J. Biol. Chem. 250, 1926–1932.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2001 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Guo, Z., Jennings, H. (2001). Protein-Polysaccharide Conjugation. In: Pollard, A.J., Maiden, M.C. (eds) Meningococcal Vaccines. Methods in Molecular Medicine™, vol 66. Humana Press.

Download citation

  • DOI:

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-801-1

  • Online ISBN: 978-1-59259-148-0

  • eBook Packages: Springer Protocols